Darvocet / Darcon Heart Damage Lawsuits

On November 19, 2010, Xanodyne Pharmaceuticals, Inc., the company that manufactures Darvocet and Darcon (i.e, propoxyphene), agreed to withdraw its brand name prescription pain medications from the market.  The recall came at the request of the Food and Drug Administration.

According to the Food and Drug Administration, "new heart data significantly alter[s] propoxyphene's risk-benefit profile.  The drug's effectiveness in reducing pain is no longer enough to outweigh the drug's serious potential heart risks."  The FDA was "pleased by Xanodyne's choice to voluntarily recall [Darvocet and Darcon] from the U.S. market."

The FDA sought market removal of propoxyphene after receiving reports of clinical data suggesting that the pain medication places patients at risk for potentially fatal heart arrhythmias and abnormalities.  According to Sharon Hertz, M.D., of the FDA,  "propoxyphene can cause problems with the heart."  She also recommended that patients taking propoxyphene consult with their physicians and "not use it any longer."  A video released by the FDA can be found here.

Potential cardiac-related side effects of Darvocet / Darcon consumption may include:
  • hypotension;
  • reduced cardiac output;
  • interruption of heart electrical impulses;
  • slowed heartbeat;
Other potential side effects may include:
  • addiction;
  • suicide; and
  • seizure.
The trial lawyers at Bottar Leone, PLLC, have decades of experience investigating, prosecuting and trying to verdict dangerous pharmaceutical and unsafe drug cases.  If you or a loved one have been injured due to a prescription medication, you and your family may be entitled to compensation for lifelong health care, medical expenses, special education, medical bills, loss of income, and pain and suffering. 

To discuss your case or concerns with an experienced Central New York Darvocet / Darcon lawsuit attorney, contact us now at (315) 422-3466, (800) 336-LAWS, or by e-mail at info@bottarleone.com.